Medicure (MCUJF) EPS (Basic) Growth (5y) (2014 - 2026)
Medicure (MCUJF) EPS (Basic) Growth (5y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.55 Bn | 39.89 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.85 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.37 Bn | 19.71 Bn | 683.80 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Medicure | 96.01 Mn | 94.89 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.49% |
| Dec 31, 2025 | 1.73% |
| Sep 30, 2025 | -5.85% |
| Jun 30, 2025 | -274.42% |
| Mar 31, 2025 | 19.22% |
| Dec 31, 2024 | 40.40% |
| Sep 30, 2024 | 29.23% |
| Jun 30, 2024 | -31.00% |
| Mar 31, 2024 | 15.18% |
| Dec 31, 2023 | -22.07% |
| Sep 30, 2023 | 66.87% |
| Jun 30, 2023 | 69.36% |
| Mar 31, 2023 | 78.80% |
| Dec 31, 2022 | -31.60% |
| Sep 30, 2022 | 40.82% |
| Jun 30, 2022 | 42.33% |
| Mar 31, 2022 | 27.91% |
| Dec 31, 2021 | -17.45% |
| Sep 30, 2021 | 16.64% |
| Jun 30, 2021 | 11.77% |